cho_logo_symbol_border

Clear Health Pass MDDrugPro

Is your patient complying with treatment plans?

Clear Health Pass MDDrugPro is designed to give providers a clear view of their patient’s drug usage. Our test panel measures the amount of medicine in a patient’s system to ensure the patient is complying with their prescribed treatment plan. Clear Health Pass MDDrugPro helps providers determine if the amount of medicine their patient is taking is both safe and effective. 

Most medicines can be dosed correctly without special testing, but for certain types of medicines, it can be hard to figure out a dose that provides enough medicine to treat a patient’s condition without causing adverse drug reactions. With Clear Health Pass MDDrugPro, doctors can survey their patients drug use and provide a better treatment plan to save them from any harmful or unpleasant reactions.  

Tracking improper drug use

MDDrugPro also offers pharmacogenomics (PGx) testing which gives an added element to drug monitoring. In choosing to run PGx testing with our MDDrugPro panel, providers can see how each patient metabolizes prescribed medications.  

How does your patient metabolize medication?

As prescription drug abuse continues to rise in the US, doctors can also use MDDrugPro to test for medication abuse. We test for a wide range of prescribed medications and give you custom panel options, which includes genetic testing. MDDrugPro also tests for illicit drugs and offers multiple collection methods. Protect your patients and your practice with MDDrugPro. 

11.7% of Americans 12 and over use illegal drugs.

Drug use is highest among persons between the ages of 18-25 at 39%

30 Wall St. 8th floor New York, NY 10005

Clear Health Pass as Specifications Developer

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

As a Specification Developer, the Company may also arrange for the manufacturing of devices labeled with another establishment’s
name by a contract manufacturer.

The distribution of collection kits, specimen transport, marketing, test distribution, and actual testing is performed by a high-complexity Clinical Laboratory Improvement Amendments (CLIA) lab.

All testing conducted by the CLIA lab is compliant with the Centers for Medicare and Medicaid Services (CMS) CLIA Lab Amendments Act.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $5,000,000

Funding Goal $5,000,000

20%

Skip to content